BROOKS LABORATORIES LTD. - 533543 - Announcement Under Regulation 30 Of SEBI (LODR), Regulations, 2015.
Announcement under Regulation 30 of SEBI (LODR), Regulations, 2015.10-05-2022
10-05-2022
BROOKS LABORATORIES LTD. - 533543 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayBROOKS LABORATORIES LTD. 2CINL24232HP2002PLC000267 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 106449.00 4Highest Credit Rating during the previous FY BB- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Jyoti Sancheti Designation: Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: Prashant Rathi Designation: Chief Financial Officer EmailId: [email protected] Date: 29/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.29-04-2022
BROOKS LABORATORIES LTD. - 533543 - Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015
Certificate from Practicing Company Secretary under Regulation 40(9) of SEBI (LODR) Regulations, 201520-04-2022
BROOKS LABORATORIES LTD. - 533543 - Compliance Certificate For Period 01.04.2021 To 31.03.2022
Compliance Certificate for period 01.04.2021 to 31.03.2022 signed by RTA and Compliance officer of the Company.13-04-2022
BROOKS LABORATORIES LTD. - 533543 - Clarification On Price Movement.
Clarification on Price Movement.11-04-2022
BROOKS LABORATORIES LTD. - 533543 - Clarification sought from Brooks Laboratories Ltd
The Exchange has sought clarification from Brooks Laboratories Ltd on April 8, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.08-04-2022
BROOKS LABORATORIES LTD. - 533543 - Closure of Trading Window
Intimation of Closure of Trading Window from 31.03.2022 till 48 hours after the declaration of the Audited Financial Results of the Company for the financial year ended 31.03.202223-03-2022
BROOKS LABORATORIES LTD. - 533543 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Standalone and Consolidated financial Results for the 3rd quarter and nine months ended 31.12.202116-02-2022
BROOKS LABORATORIES LTD. - 533543 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The 3Rd Quarter Ended 31.12.2021
BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 ,inter alia, to consider and approve approval of Unaudited financial results for the 3rd quarter ended 31.12.202104-02-2022